Predicting survival of pancreatic cancer patients treated with gemcitabine using longitudinal tumour size data


Measures derived from longitudinal tumour size data have been increasingly utilised to predict survival of patients with solid tumours. The aim of this study was to examine the prognostic value of such measures for patients with metastatic pancreatic cancer undergoing gemcitabine therapy. The control data from two Phase III studies were retrospectively used… (More)
DOI: 10.1007/s00280-016-2994-x

6 Figures and Tables


  • Presentations referencing similar topics